<unk>  (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases. The drug was approved in Europe in March 2009.
Mifamurtide
Iofendylate
Nesiritide
Isoetarine
Iopydol
Iotrolan
Oprelvekin
Guanadrel